Serum procalcitonin levels in the postmortem diagnosis of sepsis

Forensic Science International

Volumn 226, Issue 1-3, 2013, Pages 266-272

  Bode Janisch S ^a   Schutz S ^a   Schmidt, A ^b   Tschernig, T ^c   Debertin, A S ^a   Fieguth, A ^a   Hagemeier, L ^a   Teske, J ^a   Suerbaum, S ^a   Klintschar, M ^a   Bange, F C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NORDSTADT HOSPITAL   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Legal medicine; Post mortem diagnosis; Procalcitonin; Sepsis

Indexed keywords

PROCALCITONIN;

ADULT; AGED; ARTICLE; AUTOPSY; BACTERIAL INFECTION; BLOOD CULTURE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FORENSIC MEDICINE; HEART; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PCT Q1 TEST; PRIORITY JOURNAL; PROCALCITONIN BLOOD LEVEL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SEPSIS; SPLEEN;

EID: 84875629716     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2013.01.041     Document Type: Article

References (43)

1. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M.H., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. ACCP/SCCM Consensus Conference Committee:.
2. Tsokos M. Postmortale sepsisdiagnose. Teil 1: Pathomorphologie. Rechtsmedizin 2006, 16:231-246.
3. Ramsthaler F., Kettner M., Mall G., Bratzke H. The use of rapid diagnostic test of procalcitonin serum levels for the postmortem diagnosis of sepsis. Forensic Sci. Int. 2008, 178:139-145.
4. Tsokos M. Postmortem diagnosis of sepsis. Forensic Sci. Int. 2007, 165:155-164.
5. Tsokos M., Reichelt U., Nierhaus A., Püschel K. Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis. Int. J. Legal Med. 2001, 114:237-243.
6. Jones A.E., Fiechtl J.F., Brown M.D., Ballew J.J., Kline J.A. Procalcitonin test in the diagnosis of bacteremia: a meta-amalysis. Ann. Emerg. Med. 2007, 50:34-41.
7. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and c-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 2004, 39:206-217.
8. Meisner M., Tschaikowsky K., Schnabel S., Schmidt J., Katalinic A., Schüttler J. Procalcitonin - influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35:597-601.
9. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infections. Lancet 1993, 341:515-518.
10. Christ-Crain M., Stolz D., Bingisser R., Müller C., Miedinger D., Huber P.R., Zimmerli W., Harbarth S., Tamm M., Müller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2006, 174:84-93.
11. Linscheid P., Seboek D., Schaer D.J., Zulewski H., Keller U., Müller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit. Care Med. 2004, 32:1715-1721.
12. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., Bohoun C. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 1994, 79:1605-1608.
13. Oberhoffer M., Stonans I., Russwurm S., Stonane E., Vogelsang H., Junker U., Jäger L., Reinhart K. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J. Lab. Clin. Med. 1999, 134:49-55.
14. Meisner M. Procalcitonin - Biochemie und klinische Diagnostik 2010, UNI-MED, Bremen.
15. Rau B., Steinbach G., Gansauge F., Mayer J.M., Grünert A., Beger H.G. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997, 41:832-840.
16. Whicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker. Ann. Clin. Biochem. 2001, 38:483-493.
17. Morgenthaler N.G., Struck J., Fischer-Schulz C., Seidel-Mueller E., Beier W., Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin. Lab. 2002, 48:263-270.
18. Hergert M., Lestin H.G., Scherkus M., Brinker K., Klett I., Stranz G., Lestin F. Procalcitonin in patients with sepsis and polytrauma. Clin. Lab. 1998, 44:659-670.
19. Püschel K. Sepsis. Handbuch gerichtliche Medizin 2004, 1034-1036. Springer, Berlin. B. Brinkmann, B. Madea (Eds.).
20. Meisner M., Brunkhorst F.M., Reith H.B., Schmidt J., Lestin H.G., Reinhart K. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin. Chem. Lab. Med. 2000, 38:989-995.
21. Sinha M., Desai S., Mantri S., Kulkarni A. Procalcitonin as an adjunctive biomarker in sepsis. Indian J. Anaesth. 2011, 55:266-270.
22. Lavrentieva A., Papadopoulou S., Kioumis J., Kaimakamis E., Bitzani M. PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment. Burns 2011, (October). (Epub ahead of print).
23. Wanner G., Keel M., Steckholzer U., Beier W., Stocker R., Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit. Care Med. 2000, 28:950-957.
24. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., Vadas L., Pugin J. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am. J. Respir. Crit. Care Med. 2001, 164:396-402. Geneva Sepsis Network.
25. Chirouze C., Schuhmacher H., Rabaud C., Gil H., Khayat N., Estavoyer J.M., May T., Hoen B. Low serum procalcitonin level accurately predicts the abscence of bacteremia in adult patients with acute fever. Clin. Infect. Dis. 2002, 35:156-161.
26. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998, 24:680-684.
27. Şentürk T., Cordan J., Baran I., Özdemir B., Güllülü S., Aydinlar A., Göral G. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol. 2007, 62:135-141.
28. Ataoĝlu H.E., Yilmaz F., Uzunhasan I., Cetin F., Temiz L.Ü., Döventaş Y.E., Kaya A., Yenigün M. Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J. Int. Med. Res. 2010, 38:52-61.
29. Sinning C.R., Sinning J.M., Schulz A., Schnabel R.B., Lubos E., Wild P.S., Papassotiriou J., Bergmann A., Blankenberg S., Munzel T., Bickel C. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ. J. 2011, 75:1184-1191. AtheroGene Study Investigators.
30. Burrati T., Ricevuti G., Pechlaner C., Joannidis M., Wiedermann F.J., Gritti D., Herold M., Wiedermann C.J. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 2001, 25:97-100.
31. Kafkas N., Venetsanou K., Patsilinakos S., Voudris V., Antonatos D., Kelesidis K., Baltopoulos G., Maniatis P., Cokkinos D.V. Procalcitonin in acute myocardial infarction. Acute Card. Care 2008, 10:30-36.
32. Fries M., Kunz D., Gressner A.M., Rossaint R., Kuhlen R. Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation 2003, 59:105-109.
33. Mongardon N., Lemiale V., Perbet S., Dumas F., Legriel S., Guérin S., Charpentier J., Chiche J.D., Mira J.P., Cariou A. Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients. Intensive Care Med. 2010, 36:92-99.
34. Brunkhorst F.M., Clark A.L., Forycki Z.F., Anker S.D. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int. J. Cardiol. 1999, 72:3-10.
35. Geppert A., Steiner A., Delle-Karth G., Heinz G., Huber K. Usefullness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenec shock. Intensive Care Med. 2003, 29:1384-1389.
36. Remskar M., Horvat M., Hojker S., Noc M. Procalcitonin in patients with acute myocardial infarction. Wien. Klin. Wochenschr. 2002, 114:205-210.
37. Christofilopoulou S., Charvalos E., Petrikkos G. Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur. J. Intern. Med. 2002, 13:493-495.
38. Nylen E.S., O'Neill W., Jordan M.H., Snider R.H., Moore C.F., Lewis M., Silva O.L., Becker K.L. Serum procalcitonin as an index of inhalation injury in burns. Horm. Metab. Res. 1992, 24:439-442.
39. Carsin H., Assicot M., Feger F., Roy O., Pennacino I., Le Bever H., Ainaud P., Bohuon C. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFα and endotoxin levels early after thermal injury. Burns 1997, 23:218-224.
40. Bianchi L., Denk H., Stolte M., Walch A., Riede U.N. Leberparenchym. Allgemeine und spezielle Pathologie 2004, 736-780. Thieme, Stuttgart. U.N. Riede, M. Werner, H.E. Schäfer (Eds.).
41. Tang B.M.P., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect. Dis. 2007, 7:210-217.
42. Riedel S., Melendez J.H., An A.T., Rosenbaum J.E., Zenilman J.M. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am. J. Clin. Pathol. 2011, 135:182-189.
43. Schuetz P., Albrich W., Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011, 9:107.